Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ENSG00000258679 gene (novel YWHA pseudogene) is classified as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but defective; they do not encode functional proteins. While its sequence resembles genes from the **YWHA** family—specifically, various 14-3-3 proteins involved in signal transduction—the pseudogene itself has no known product, function, or therapeutic relevance. It is referenced primarily as an annotation in genomic databases[1]. **Note:** - The functional YWHA gene family (such as YWHAE, YWHAH, and YWHAG) encode 14-3-3 proteins that play important roles in signal transduction, cell cycle, neuronal migration, cancer, and other diseases[2][3][4][6][7]. - The **novel YWHA pseudogene** (ENSG00000258679) does **not** encode any of these active proteins and should not be confused with them. If you require information about a functional member of the YWHA gene family (such as YWHAE or YWHAH), specify that gene, as those are valid therapeutic targets with well-characterized biological functions and disease associations[2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel YWHA pseudogene (ENSG00000258679).